Lifeboat Foundation

Should definitely be worked on. Eventually the same stuff could be used to reverse engineer/terraform Venus.

When politicians talk about the Paris Climate Agreement, it’s usually framed in terms of restrictions on emissions for states and businesses. But the Paris Agreement wasn’t just an agreement to regulate — it was also an agreement to innovate. That’s because most experts agree that the world won’t be able to keep global temperature rise below 2 degrees Celsius, unless there’s a way to physically remove CO₂ from the atmosphere.

A Swiss startup called Climeworks has made that their goal, developing the most advanced carbon-capture technology to date. VICE News went to Switzerland to see how the technology works and hear how the business plans to tackle climate change. Problem is, what Climeworks is doing isn’t cheap.

Continue reading “Sucking CO2 from the atmosphere could save the planet — but it isn’t cheap” »

A research team at MIT has used synthetic biology to create a gene circuit that triggers the immune system to attack cancer when it first detects the signs of the disease.

The circuit works by only activating the immune response when two specific cancer biomarkers are detected. The new study was published in the journal Cell this week and represents an exciting step forward for synthetic biology and cancer research.

This announcement comes just a few days after the UAE announced their UAE 2031 AI strategy, which aims to make the government more efficient and streamlined by relying on AI technologies.

The United Arab Emirates (UAE) appears to be leading new trends in government reshuffles, now having introduced its first Minister for Artificial Intelligence.

Continue reading “UAE appoints first-ever Minister for Artificial Intelligence” »

D-Wave system shows quantum computers can learn to detect particle signatures in mountains of data, but doesn’t outpace conventional methods — yet.

• By Davide Castelvecchi, Nature on October 22, 2017

How many individuals own at least 1 BTC?

I was asked this question today at Quora, a popular Q&A blog covering a variety of technical and economic disciplines. Under my alias “Ellery”, I am the most viewed author on Bitcoin and the blockchain.

While this question may sound like a good factoid for a trivia game, it is directly related to something with with far reaching impact on your pocketbook and your future. It goes to the heart of a debate between warring factions: In the 2nd half of this answer, I address the eternal question:

Is Bitcoin a pyramid scheme? Or are we still early on the adoption curve?

Continue reading “What can we learn from small fraction of people who own 1 BTC” »

Parent company Alphabet would provide services in response to data harvested.

This man is modifying his genes to make himself stronger.

ProPublica has been documenting the many ways health care dollars are being wasted. We’ve shown how hospitals throw out brand new supplies, nursing homes flush tons of unexpired medication and drug companies concoct costly combinations of cheap medication. Recently we described how arbitrary drug expiration dates cause us to toss safe and potent medicine.

Often, large swaths of the medical and pharmaceutical communities know about this waste — even about solutions to it — but do nothing. Those who end up paying the bill, in one way or another, are consumers.

Continue reading “Drug Companies Make Eyedrops Too Big — And You Pay for the Waste” »

Can the process of aging be delayed or even reversed? Research led by specially appointed Professor Jun-Ichi Hayashi from the University of Tsukuba in Japan has shown that, in human cell lines at least, it can. They also found that the regulation of two genes involved with the production of glycine, the smallest and simplest amino acid, is partly responsible for some of the characteristics of aging.